Business
EU regulators reviewing J&J’s COVID vaccine after blood clots – Aljazeera.com
Johnson & Johnson is working with EU regulators to assess data on the rare clots, the company said in a statement.
The European Unions drug regulator has started a review to assess blood clots in people who received Johnson & Johnsons Covid-19 vaccine.
Four serious cases of unusual clots accompanied by low blood platelets, one of which was fatal, have emerged after immunization with the J&J shot, the European Medicines Agency said Friday. The regulator is now scrutinizing potential safety issues for two Covid vaccines, after AstraZeneca Plcs shot was possibly linked to a rare blood-clotting disorder.
J&J is…
-
Noosa News23 hours agoDrivers call out bad manners and most hated acts on Queensland roads
-
Business24 hours agoHow to build a $250,000 passive income portfolio starting from zero
-
Noosa News23 hours agoLyvin Melasti at Melasti Beach
-
Noosa News23 hours agoCoochin Fields developer asked to explain shortfalls in tourist park proposal